Methodological Issues in the Study of Drug Effects on Cognitive Skills in Mental Retardation

International Review of Research in Mental Retardation

Volumn 21, Issue C, 1997, Pages 147-185

  Williams, Dean C ^a   Saunders, Kathryn J ^a  

^a Parsons Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343086326     PISSN: 00747750     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7750(08)60279-7     Document Type: Chapter

References (136)

1. Aman M.G. Drugs, learning, and the psychotherapies. In: Werry J.S. (Ed). Pediatric psy-chopharmacology. The use of behavior modifying drugs in children (1978), Brunner/Mazel, New York 79-108
2. Aman M.G. Drugs and learning in mentally retarded persons. In: Burrows G.D., and Werry J.S. (Eds). Advances in human psychopharmacology 3 (1984), JAI Press, Greenwich, CT 121-163
3. Aman M.G. Applications of computerized cognitive-motor measures to the assessment of psy-choactive drugs. In: Dodson W.E., Kinsbourne M., and Hiltbrunner B. (Eds). The assessment of cognitive function in epilepsy (1991), Demos Publications, New York 69-96
4. Aman M.G., and Kern R.A. Review of fenfluramine in the treatment of the developmental disabilities. Journal of the American Academy of Child and Adolescent Psychiatry 28 (1989) 549-565
5. Aman M.G., Kern R.A., McGhee D.E., and Arnold L.E. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects. Journal of Autism and Developmental Disorders 23 (1993) 1-16
6. Aman M.G., and Singh N.N. The usefulness of thioridazine for treating childhood disorders- Fact or folklore?. American Journal of Mental Deficiency 84 (1980) 331-338
7. Aman M.G., and Singh N.H. Patterns of drug use, methodological considerations, measurement techniques, and future trends. In: Aman M.G., and Singh N.N. (Eds). Psychopharmacology of the developmental disabilities (1988), Springer-Verlag, New York 1-28
8. Aman M.G., and White A.J. Measures of drug change in mental retardation. In: Gadow K.D. (Ed). Advances in learning and behavioral disabilities 5 (1986), JAI Press, Greenwich, CT 157-202
9. Anderson L.T., Campbell M., Grega D.M., Perry R., Small A.M., and Green W.H. Haloperi-dol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry 141 (1984) 1195-1202
10. Anderson L.T., Campbell M., Adams P., Small A.M., Perry R., and Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. Journal of Autism and Development Disorders 19 (1989) 227-239
11. Baldessarini R.J. Drugs and the treatment of psychiatric disorders. In: Gilman A.G., et al. (Ed). Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. (1990), Pergamon, New York 383-435
12. Baldessarini R.J., and Frankenburg F.R. Clozapine: A novel antipsychotic agent. In: Yesav-age J. (Ed). Clozapine: A compendium of selected readings. 2nd ed. (1993), San-doz Pharmaceuticals Corp, Stanford, CA 3-16
13. Barlow D.H., and Hersen M. Single case experimental designs (1984), Pergamon Press, New York
14. Baron A., and Galizio M. Instructional control of human operant behavior. The Psychological Record 33 (1983) 495-520
15. Baron A., Myerson J., and Hale S. An integrated analysis of the structure and function of behavior: Aging and the cost of dividing attention. In: Davey G., and Cullen C. (Eds). Human operant conditioning and behavior modification (1988), John Wiley & Sons, New York 139-166
16. Barrett J.E. Effects of alcohol, chlordiazepoxide, cocaine and pentobarbital on responding maintained under fixed-interval schedules of food or shock presentation. Journal of Pharmacology and Experimental Therapeutics 196 (1976) 605-615
17. Baumeister A.A., and Sevin J.A. Pharmacologic control of aberrant behavior in the mentally retarded: Toward a more rational approach. Neuroscience & Biobehavioral Reviews 14 (1990) 253-262
18. Baumeister A.A., Todd M.E., and Sevin J.A. Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation. Clinical Neuropharmacology 16 (1993) 271-294
19. Bickel W.K., Higgins S.T., and Griffiths R.R. Repeated diazepam administration: Effects on the acquisition and performance of response chains in humans. Journal of the Experimental Analysis of Behavior 52 (1989) 47-56
20. Bickel W.K., Higgias S.T., and Hughes J.R. The effects of diazepam and triazolam on repeated acquisition and performance of response sequences with an observing response. Journal of the Experimental Analysis of Behavior 56 (1991) 217-237
21. Boren J.J. The repeated acquisition of new behavioral chains. American Psychologist 18 (1963) 421 (Abstract)
22. Boren J.J., and Devine D.D. The repeated acquisition of behavioral chains. Journal of the Experimental Analysis of Behavior 11 (1968) 651-660
23. Branch M.N. Rate, dependency, behavioral mechanisms, and behavioral pharmacology. Journal of the Experimental Analysis of Behavior 42 (1984) 511-522
24. Branch M.N. Behavioral pharmacology. In: Iversen I.H., and Lattal K.A. (Eds). Experimental analysis of behavior. Part 2 (1991), Elsevier, New York 21-77
25. Bustillo J.R., Kirkpatrick B., and Buchanan R.W. Neuroleptic treatment and negative symptoms in deficit and nondefrcit schizophrenia. Biological Psychiatry 38 (1995) 64-67
26. Campbell D.T., and Stanley J.C. Experimental and quasi-experimental designs for research (1963), Rand McNally, Chicago, IL
27. Campbell M., Anderson L.T., Small A.M., Locascio J.J., Lynch N.S., and Choroco M.C. Naltrexone in autistic children: A double-blind and placebo-controlled study. Psychopharmacol-ogy Bulletin 26 (1990) 130-135
28. Campbell M., Anderson L.T., Small A.M., Perry R., Green W.H., and Caplan R. The effects of haloperidol on learning and behavior in autistic children. Journal of Autism and Developmental Disorders 12 (1982) 167-175
29. Carr E.C., and Durand V.M. Reducing behavior problems through functional communication training. Journal of Applied Behavior Analysis 18 (1985) 111-126
30. Carter D.E., and Eckerman D.A. Symbolic matching by pigeons: Rate of learning complex discriminations predicted from simple discriminations. Science 187 (1975) 662-664
31. Catania C.A. Learning. 3rd ed. (1992), Prentice-Hall, Englewood Cliffs, NJ
32. Cohen S.A., and Underwood M.T. The use of clozapine in a mentally retarded and aggressive population. Journal of Clinical Psychiatry 55 (1994) 440-444
33. Constantine B., and Sidman M. Role of naming in delayed matching-to-sample. American Journal of Mental Deficiency 79 (1975) 680-689
34. Cumming W.W., and Berryman R. The complex discriminated operant: Studies of matching-to-sample and related problems. In: Mostofsky D.I. (Ed). Stimulus generalization (1965), Stanford University Press, Stanford, CA 284-330
35. Dalton A.J. Dementia in Down syndrome: Methods of evaluation. In: Nadel L., and Epstein C. (Eds). Down syndrome and Alzheimer disease (1992), Wiley-Liss, New York 51-76
36. Dalton A.J., and Crapper McLachlan D.R. Incidence of memory deterioration in aging persons with Down's syndrome. In: Berg J.M. (Ed). Perspectives and progress in mental retardation. Vol. 11: Biomedical aspects (1984), University Park Press, Baltimore, MD 55-62
37. Dalton A.J., Crapper McLachlan D.R., and Schlotterer G.R. Alzheimer's disease in Down's Syndrome: Visual retention deficits. Cortex 10 (1974) 366-377
38. Desjardins P.J., Moerschbaecher J.M., Thompson D.M., and Thomas J.R. Intravenous di-azepam in humans: Effects on acquisition and performance of response chains. Pharmacology Biochemistry and Behavior 17 (1982) 1055-1059
39. Detterman D.K., Mayer J.D., Caruso D.R., Legree P.J., Corners F.A., and Taylor R. Assessment of basic cognitive abilities in relation to cognitive defects. American Journal on Mental Retardation 97 (1992) 251-286
40. Dews P.B. Studies on behavior. IV. Stimulant action of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics 122 (1958) 137-147
41. Dews P.B. History and present status of rate-dependency investigations. Advances in Behavioral Pharmacology 3 (1981) 111-118
42. Dube W.V., Iennco F.M., and McIlvane W.J. Generalized identity matching to sample of two-dimensional forms in individuals with intellectual disabilities. Research in Developmental Disabilities 14 (1993) 457-477
43. Dube W.V., McIlvane W.J., and Green G. An analysis of generalized identity matching-to-sample test procedures. The Psychological Record 42 (1992) 17-28
44. Durwen H.F., Hufnagel A., and Elger C.E. Anticonvulsant drugs affect particular steps of verbal memory processing-An evaluation of 13 patients with intractable complex partial seizures of left temporal lobe origin. Neuropsychologia 30 (1992) 623-631
45. Ellis C.R., Singh N.N., and Landrum T.J. Pharmacotherapy: I. Journal of Developmental and Physical Disabilities 5 1 (1993) 1-4
46. Evenden J.L. Issues in behavioral pharmacology implications for developmental disorders. In: Aman M.G., and Singh N.N. (Eds). Psychopharmacology of the developmental disabilities (1988), Springer-Verlag, New York 216-238
47. Ferster C.B., and Skinner B.F. Schedules of reinforcement (1957), Prentice-Hall, Englewood Cliffs, NJ
48. Files F.J., Branch M.N., and Clody D. Effects of methylphenidate on responding under extinction in the presence and absence of conditioned reinforcement. Behavioral Pharmacology 1 (1989) 113-121
49. Gadow K.D. Children on medication, Vol. 1: Hyperactivity, learning disabilities, and mental retardation (1986), Little, Brown and Company, Boston, MA
50. Gadow K.D., and Poling A.D. Pharmacotherapy and mental retardation (1988), College Hill Press, Boston, MA
51. Galizio M., and Alien A.R. Variable-ratio schedules of time out from avoidance: Effects of d-amphetamine and morphine. Journal of the Experimental Analysis of Behavior 56 (1991) 193-203
52. Goldman R.S., Tandon R., Liberzon I., Goodson J., and Greden J.F. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia. Psychopathology 24 (1991) 247-252
53. Gollub L.R. The relations among measures of performance on fixed-interval schedules. Journal of the Experimental Analysis of Behavior 7 (1964) 337-343
54. Cualtieri C.T. Neuropsychiatry and behavioral pharmacology (1991), Springer-Verlag, New York
55. Hammock R., Schroeder S.R., and Levine W.A. Clozapine for self-injurious behavior. Jour-nal of Autism and Developmental Disorders 25 (1995) 611-627
56. Hartlage L.C. Effect of chlorpromazine on learning. Psychological Bulletin 4 (1965) 235-245
57. Herman B.H. Effects of opioid receptor antagonists in the treatment of autism and self-injurious behavior. In: Ratey J.J. (Ed). Mental retardation: Developing pharmacotherapies (1991), American Psychiatric Press, Washington, DC 107-137
58. Hersen M., and Barlow D.H. Single case experimental designs: Strategies for studying behavior change (1976), Pergamon Press, New York
59. Higgins S.T., Bickel W.K., O'Leary D.K., and Yingling J. Acute effects of ethanol and di-azepam on the acquisition and performance of response sequences in humans. Journal of Pharmacology and Experimental Therapeutics 243 (1987) 1-8
60. Higgins S.T., Rush C.R., Hughes J.R., Bickel W.K., Lynn M., and Capeless M.A. Effects of cocaine and alcohol, alone and in combination, on human learning and performance. Journal of the Experimental Analysis of Behavior 58 (1992) 87-105
61. Higgias S.T., Woodward B.M., and Henningfield J.E. Effects of atropine on the repeated acquisition and performance of response sequences in humans. Journal of the Experimental Analysis of Behavior 51 (1989) 5-15
62. Hursh S.R. The conditioned reinforcement of repeated acquisition. Journal of the Experimental Analysis of Behavior 27 (1977) 315-326
63. Johnston J.M., and Pennypacker H.S. Strategies and tactics of human behavioral research (1980), Lawrence Erlbaum, Hillsdale, NJ
64. Katz J.L. Effects of drugs on stimulus control of behavior. I. Independent assessment of effects on response rates and stimulus control. Journal of Pharmacology and Experimental Therapeutics 223 (1982) 617-623
65. Katz J.L. Effects of drugs on stimulus control of behavior. II. Degree of stimulus control as a determinant of effect. Journal of Pharmacology and Experimental Therapeutics 226 (1983) 756-763
66. Kaufman M.E., and Prehm H.J. A review of research on learning sets and transfer of training in mental defectives. In: Ellis N.R. (Ed). International review of research in mental retardation 2 (1966), Academic Press, New York 123-149
67. Kelleher R.T., and Morse W.H. Determinants of the specificity of the behavioral effects of drugs. Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie 60 (1968) 1-56
68. Kinchla R.A. Attention. In: Rosenzweig M.R., and Porter L.W. (Eds). Annual review of psychology 43 (1992), Annual Reviews, Palo Alto, CA 711-742
69. Lancioni G.E., and Smeets P.M. Procedures and parameters of errorless discrimination training with developmentally impaired individuals. In: Ellis N.R., and Bray N.W. (Eds). International review of research in mental retardation 14 (1986), Academic Press, New York 135-164
70. Leander J.D. Rate-dependence and the effects of phenothiazine antipsychotics in pigeons. Advances in Behavioral Pharmacology 3 (1981) 21-37
71. Louttit R.T. Chemical facilitation of intelligence among the mentally retarded. American Journal of Mental Deficiency 69 (1965) 495-501
72. Mackay H.A. Conditional stimulus control. In: Iversen I.H., and Lattal K.A. (Eds). Experimental analysis of behavior. Part 1 (1991), Elsevier, New York 301-350
73. Mackay H.A., and Gould O.D. Relative sample recency and proactive interference in adults with mental retardation. Experimental Analysis of Human Behavior Bulletin 10 (1992) 1-5
74. McIlvane W.J. Stimulus control analysis and nonverbal instructional methods for people with intellectual disabilities. In: Bray N.W. (Ed). International review of research in mental retardation 18 (1992), Academic Press, New York 55-109
75. McKeamey J.W. Rate dependency: Scope and limitations in the explanation and analysis of the behavioral effects of drugs. Advances in Behavioral Pharmacology 3 (1981) 91-109
76. Meltzer H.Y., Lee M.A., and Ranjan R. Recent advances in the pharmacotherapy of schizophrenia. Acta Psychiatrica Scandinavica 384 (1994) 95-101
77. Merrill E.C. Attentional resource allocation and mental retardation. In: Bray N.W. (Ed). International review of research in mental retardation 16 (1990), Academic Press, San Diego 51-88
78. Möller H.-J. Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties. European Neuropsychopharmacology 3 (1993) 1-11
79. Möller H.-J., Müller H., Borison R.L., Schooler N.R., and Chouinard G. A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients: A re-evaluation of the North American risperidone study. European Archives of Psychiatry Clinical Neuroscience 245 (1995) 45-49
80. Novelly R.A., Schwartz M.M., Mattson R.H., and Cramer J.A. Behavioral toxicity associated with antiepileptic drugs: Concepts and methods of assessment. Epilepsia 27 (1986) 331-340
81. Overton D.A. Discriminative control of behavior by drug states. In: Thompson T., and Pick-ens R. (Eds). Stimulus properties of drugs (1971), Appleton-Century-Crofts, New York 87-110
82. Parasuraman R., and Giambra L. Skill development in vigilance: Effects of event rate and age. Psychology and Aging 6 (1991) 155-169
83. Perone M. Experimental design in the analysis of free-operant behavior. In: Iversen I.H., and Lattal K.A. (Eds). Experimental analysis of behavior. Part 1 (1991), Elsevier, New York 135-171
84. Perone M., and Baron A. Age-related effects of pacing on acquisition and performance of response sequences: An operant analysis. Journal of Gerontology 37 (1982) 443-449
85. Perryman R.E., Halcomb C.R., and Landers W.F. Operant conditioning of mental retardates' visual monitoring. Perceptual and Motor Skills 53 (1981) 507-512
86. Picker M., Leibold L., Endsley B., and Poling A. Effects of clonazepam and ethosuximide on the responding of pigeons under a fixed-consecutive-number schedule with and without an external discriminative stimulus. Psychopharmacology 88 (1986) 325-330
87. Poling A., and Cleary J. Within-subject designs. In: Gadow K.D., and Poling A. (Eds). Advances in learning and behavioral disabilities, Suppl. 1 Methodological issues in human psychopharmacology (1986), JAI Press, Greenwich, CT 115-136
88. Poling A., Cleary J., Berens K., and Thompson T. Neuroleptics and learning: Effects of haloperidol, molindone, mesoridazine and thioridazine on the behavior of pigeons under a repeated acquisition procedure. Journal of Pharmacology and Experimental Therapeutics 255 (1990) 1240-1245
89. Poling A., Gadow K.D., and Cleary J. Drug therapy for behavior disorders: An introduction (1991), Pergamon Press, New York
90. Poling A., Henningfield J.E., and Wysocki T. Behavioral pharmacology and principles of drug action. In: Gadow K.D., and Poling A. (Eds). Advances in learning and behavioral disabilities, Suppl. 1 Methodological issues in human psychopharmacology (1986), JAI Press, Greenwich, CT 1-39
91. Poling A., and Picker M. Behavioral effects of anticonvulsant drugs. In: Thompson T., Dews P.B., and Barrett J.E. (Eds). Neurobehavioral pharmacology (1987), Lawrence Erlbaum, Hillsdale, NJ 157-192
92. Rapport M.D., DuPaul G.J., and Smith N.F. Rate-dependency and hyperactivity: Methylphenidate effects on operant responding. Pharmacology Biochemistry & Behavior 23 (1985) 77-83
93. Rapport M.D., and Kelly K.L. Psychostimulant effects on learning and cognitive function: Findings and implications for children with attention deficit hyperactivity disorder. Clinical Psychology Review 11 (1991) 61-92
94. Ratey J.J., and Gualtieri C.T. Neuropsychiatry and mental retardation. In: Ratey J.J. (Ed). Mental retardation: Developing pharmacotherapies (1991), American Psychiatric Press, Washington, DC 1-17
95. Saunders K.J., and Spradlin J.E. Conditional discrimination in mentally retarded adults: The effect of training the component simple discriminations. Journal of the Experimental Analysis of Behavior 52 (1989) 1-12
96. Saunders K.J., and Spradlin J.E. Conditional discrimination in mentally retarded adults: The development of generalized skills. Journal of the Experimental Analysis of Behavior 54 (1990) 239-250
97. Saunders K.J., and Spradlin J.E. Conditional discrimination in mentally retarded subjects: Programming acquisition and learning set. Journal of the Experimental Analysis of Behavior 60 (1993) 571-585
98. Schaal D.W., and Hackenberg T. Toward a functional analysis of drug treatment for behavior problems in people with developmental disabilities. American Journal on Mental Retardation 99 (1994) 123-140
99. Schroeder S.R. Neuroleptic medications for persons with developmental disabilities. In: Aman M.G., and Singh N.N. (Eds). Psychopharmacology of the developmental disabilities (1988), Springer-Verlag, New York 82-100
100. Scott K.G. Recognition memory: A research strategy and a summary of initial findings. In: Ellis N.R. (Ed). International review of research in mental retardation 5 (1971), Academic Press, New York 83-111
101. Share J.B. Review of drug treatment for Down's syndrome persons. American Journal of Mental Deficiency 80 (1976) 388-393
102. Shriffrin R.M. Attention. In: Atkinson R.C., Hernstein R.J., Lindzey G., and Luce R.D. (Eds). Stevens' handbook of experimental psychology Vol. 2: Learning and cognition. 2nd. ed. (1988), John Wiley & Sons, New York 739-811
103. Sidman M. Tactics of scientific research: Evaluating experimental data in psychology (1960), Basic Books, New York
104. Singh N.N., Singh Y.N., and Ellis C.R. Psychopharmacology of self-injury. In: Luisel-li J.K., Matson J.L., and Singh N.N. (Eds). Self-injurious behavior. Analysis, assessment, and treatment (1992), Springer-Verlag, New York 307-351
105. Singh N.N., and Winton A.S.W. Behavioral monitoring of pharmacological interventions for self-injury. Applied Research in Mental Retardation 5 (1984) 161-170
106. Singh Y.N., Ricketts R.W., Ellis C.R., and Singh N.N. Opioid antagonists. I: Pharmacology and rationale for use in treating self-injury. Journal of Developmental and Physical Disabilities 5 (1993) 5-16
107. Sokol M.S., and Campbell M. Novel psychoactive agents in the treatment of developmental disorders. In: Aman M.G., and Singh N.N. (Eds). Psychopharmacology of the developmental disabilities (1988), Springer-Verlag, New York 146-167
108. Sovner R. Use of anticonvulsant agents for treatment of neuropsychiatric disorders in the de-velopmentally disabled. In: Ratey J.J. (Ed). Mental retardation: Developing pharmacotherapies (1991), American Psychiatric Press, Washington, DC 83-106
109. Spradlin J.E., Locke B.J., and Fulton R.T. Conditioning and audiological assessment. In: Fulton R.T., and Lloyd L.L. (Eds). Audiometry for the retarded with implications for the difficult-to-test (1969), The Williams & Wilkins Company, Baltimore, MD 125-163
110. Sprague R.L., Barnes K.R., and Werry J.S. Methylphenidate and thioridazine: Learning, reaction time, activity, and classroom behavior in disturbed children. American Journal of Or-thopsychiatry 40 (1970) 615-628
111. Sprague R.L., and Werry J.S. Methodology of psychopharmacological studies with the retarded. In: Ellis N.R. (Ed). International review of research in mental retardation (1971), Academic Press, New York 147-219
112. Stoddard L.T., and McIlvane W.J. Establishing control by spoken words with profoundly mentally retarded individuals. Research in Developmental Disabilities 10 (1989) 141-151
113. Stromer R., McIlvane W.J., Dube W.V., and Mackay H.A. Assessing control by elements of complex stimuli in delayed matching to sample. Journal of the Experimental Analysis of Behavior 59 (1993) 83-102
114. Taylor D.V., Hetrick W.P., Neri C.L., Touchette P., Barron J.L., and Sandman C.A. Effect of naltrexone upon self-injurious behavior, learning and activity: A case study. Pharmacology Biochemistry & Behavior 40 (1991) 79-82
115. Terrace H.S. Discrimination learning with and without "errors.". Journal of the Experimental Analysis of Behavior 6 (1963) 1-27
116. Terrace H.S. Errorless discrimination learning in the pigeon: Effects of chlorpromazine and imipramine. In: Thompson T., Pickens R., and Meisch R.A. (Eds). Readings in behavioral pharmacology (1970), Appleton-Century-Crofts, New York 112-115
117. Thomas J.R. Differential effects of two phenothiazines on chain and tandem schedule performance. In: Thompson T., Pickens R., and Meisch R.A. (Eds). Readings in Behavioral Pharmacology (1970), Appleton-Century-Crofts, New York 432-441
118. Thompson D.M. Repeated acquisition of response sequences: Stimulus control and drugs. Journal of the Experimental Analysis of Behavior 23 (1975) 429-436
119. Thompson D.M. Developmental tolerance to the disruptive effects of cocaine on repeated acquisition and performance of response sequences. Journal of Pharmacology and Experimental Therapeutics 203 (1977) 294-302
120. Thompson D.M. Selective antagonism of the rate-decreasing effect of d-amphetamine by chlorpromazine in a repeated-acquisition task. Journal of the Experimental Analysis of Behavior 34 (1980) 87-92
121. Thompson D.M., and Moerschbaecher J.M. Drug effects on repeated acquisition. In: Thompson T., and Dews P.B. (Eds). Advances in behavioral pharmacology 2 (1979), Academic Press, New York 229-255
122. Thompson T., Hackenberg T., and Schaal D.W. Pharmacological treatments for behavior problems in developmental disabilities (1991), National Institute of Child Health and Human Development, Washington, DC 343-439 Publication No. 91-2410
123. Thompson T. Foreword. In: Breuning S.E., and Poling A.D. (Eds). Drugs and mental retardation (1982), Charles C. Thomas, Springfield, IL vii-vix
124. Vanden Boore R., Vermote R., Buttiëns M., Thiry P., Dierick G., Geutjens J., Sieben G., and Heylen S. Risperidone as add-on therapy in behavioural disturbances in mental retardation: A double-blind placebo-controlled cross-over study. Acta Psychiatrica Scandinavica 87 (1993) 167-171
125. Vaughan M.E. Repeated acquisition in the analysis of rule-governed behavior. Journal of the Experimental Analysis of Behavior 44 (1985) 175-184
126. Warm J.S., and Berch D.B. Sustained attention in the mentally retarded: The vigilance paradigm. In: Ellis N.R., and Bray N.W. (Eds). International review of research in mental retardation 13 (1985), Academic Press, New York 1-41
127. Waters J.M., Hardy P.M., and Cohen M.S. Interactions of medication and programming: A clinical approach. In: Mulick J.A., and Anlonak R.F. (Eds). Transitions in mental retardation Vol. 2: Issues in therapeutic intervention (1987), Ablex Publishing, Norwood, NJ 211-234
128. Werry J.S. Measures in pediatric psychopharmacology. In: Werry J.S. (Ed). Pediatric psychopharmacology: The use of behavior modifying drugs in children (1978), Brunner/Mazel, New York 29-36
129. Werry J.S. Conclusions. In: Aman M.G., and Singh N.N. (Eds). Psychopharmacology of the developmental disabilities (1988), Springer-Verlag, New York 239-245
130. Werry J.S., and Sprague R.L. Psychopharmacology. In: Words J. (Ed). Mental retardation 4 (1972), Grune & Stratton, New York 63-79
131. Whalen C.K., and Henker B. Group designs in applied psychopharmacology. In: Gadow K.D., and Poling A. (Eds). Advances in learning and behavioral disabilities, Suppl. 1 Methodological issues in human psychopharmacology (1986), JAI Press, Greenwich, CT 137-222
132. Wittenborn J.R. Behavioral toxicity in normal humans as a model for assessing behavioral toxicity in patients. In: Lipton M.A., DiMascio A., and Killam K.F. (Eds). Psychopharmacology: A generation of progress (1978), Raven Press, New York 791-796
133. Wolfensberger W., and Menolascino F. Basic considerations in evaluating ability of drugs to stimulate cognitive development in retardates. American Journal of Mental Deficiency 73 (1968) 414-423
134. Wysocki T., Fuqua W., Davis V.J., and Breuning S.E. Effects of thioridazine (Mellaril) on titrating delayed matching-to-sample performance of mentally retarded adults. American Journal of Mental Deficiency 85 (1981) 539-547
135. Zeaman D., and House B.J. The role of attention in retardate discrimination learning. In: Ellis N.R. (Ed). Handbook of mental deficiency: Psychological theory and research (1963), McGraw-Hill, New York 159-223
136. Zygmont D.M., Lazar R.M., Dube W.V., and McIlvane W.J. Teaching arbitrary matching via sample stimulus-control shaping to young children and mentally retarded individuals: A methodological note. Journal of the Experimental Analysis of Behavior 57 (1992) 109-117